Your browser doesn't support javascript.
loading
Unmet needs and practical solutions in the management of invasive mould infections in Asia.
Chen, Yee Chun; Chayakulkeeree, Methee; Chakrabarti, Arunaloke; Gan, Gin Gin; Kwong, Yok Lam; Liu, Wei-Lun; Tan, Ban Hock; Todi, Subhash.
  • Chen YC; Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Chayakulkeeree M; Division of Infectious Diseases and Tropical Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Chakrabarti A; Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • Gan GG; Doodhadhari Burfani Hospital and Research Institute, Haridwar, India.
  • Kwong YL; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Liu WL; Division of Haematology, Oncology and Bone Marrow Transplantation, University of Hong Kong, Pokfulam, Hong Kong.
  • Tan BH; School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan.
  • Todi S; Division of Critical Care Medicine, Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei, Taiwan.
J Antimicrob Chemother ; 77(10): 2579-2585, 2022 09 30.
Article en En | MEDLINE | ID: mdl-35904002
Management of invasive mould infections (IMIs) is challenging in Asia, as awareness among medical practitioners can be low and resources are limited. Timely diagnosis and appropriate treatment of IMIs can mitigate the impact on morbidity and mortality, but diagnostic methods, as well as access to preferred antifungal medications, may vary throughout the region. Knowledge of local epidemiology and accurate diagnosis and identification of causal pathogens would facilitate optimal treatment but data in Asia are lacking. To address these unmet needs in the management of IMIs, this paper is a call for urgent action in the following areas: improving awareness of the threat of IMIs; providing education to frontline clinicians across a broad range of specialties on 'red flags' for suspicion of IMIs; prioritizing cost-effective rapid diagnostic testing; improving access to preferred antifungal medications; and closing the gaps in local epidemiological data on IMIs to inform local treatment guidelines.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hongos / Antifúngicos Tipo de estudio: Guideline País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hongos / Antifúngicos Tipo de estudio: Guideline País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article